The global effect of ubiquitin-proteasome (UP) inhibitors on leukemic cell proteome was analysed. A total of 39 protein spots, affected by UP inhibitors, were identified, including 11 new apoptosis-associated proteins. They are involved in different cellular functions and four were associated with caspase-3 activation. Eukaryotic initiation factor 5A (eIF-5A) was identified in two spots; however, the peptide mass-fingerprinting for the accumulated one included a peptide with lysine 50 , indicating that hypusine formation was suppressed during UP inhibitor-induced apoptosis. Hypusine modification ensues immediately following translation of eIF-5A precursor, unless cells are treated with the modification inhibitors diaminoheptane. However, UP inhibitors induced a much stronger accumulation of unmodified eIF-5A compared to the effect of diaminoheptane. We further showed the unmodified eIF-5A was regulated in a proteasome-dependent manner. Inhibition of hypusine formation by diaminoheptane triggered apoptosis, but of particular interest is the finding that eIF-5A expression inhibition by antisense oligodeoxynucleotides significantly enhanced the stimulating effect of GM-CSF on cell growth. Therefore, the eIF-5A accumulation played important roles in the apoptosis induced by UP inhibitors. Moreover, hypusine inhibition in apoptosis was further revealed to be associated with the subcellular localization of eIF-5A. Our data pave the way to a better understanding of the mechanisms by which UP system has been linked to apoptosis.
Introduction
The ubiquitin-proteasome (UP) system is the major extralysosomal pathway responsible for intracellular protein degradation in eukaryotes (Pickart, 2001) . It is composed of the ubiquitin-conjugating system and the 26S proteasome, the latter of which contains the multicatalytic protease complex, also known as the 20S proteasome, as its proteolytic core. Coordinated function of the ubiquitin-conjugating system involves several classes of enzymes including a ubiquitin-activating enzyme (E1), ubiquitin-conjugating enzyme (E2), ubiquitin ligase (E3) and also ubiquitin hydrolases. In combination with a target protein, the activity of this pathway results in mono-or polyubiquitination. Polyubiquitinated proteins are targets for degradation by the proteasome, a large multisubunit particle found in the nucleus and cytoplasm of eukaryotic cells (Pickart, 2001) .
Function of the UP pathway is necessary for cell growth by regulating the entry and exit to and from the mitotic cycle through timely degradation of cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors (Hershko and Ciechanover, 1998) . The proteasome is also associated with many other important functions, including degradation of transcription factors, antigen processing, angiogenesis and other short-lived regulatory proteins (Lee and Goldberg, 1998; Pickart, 2001; . The importance of the proteasomes in the processing of these events has been established largely by the use of specific proteasome inhibitors (Lee and Goldberg, 1998) . Moreover, these UP inhibitors have been shown to induce apoptosis in several human cell lines (Zhang et al., 1999) . Although significant information is available regarding the effect of UP inhibitors on specific intracellular regulatory mechanisms, for example, regulation of the cell cycle and apoptosis (Caraglia et al., 2001; , an analysis of the global effect of UP inhibitors on cell proteome has not been reported. Since such an analysis is expected to provide more complete and unbiased insight into the regulatory mechanisms, we studied the changes in the proteome of several leukemic cell lines and others in response to treatment with UP inhibitors. These cells have been shown to be very sensitive to the treatment of UP inhibitors, and their proliferation was potently inhibited by the treatment (Zhang et al., 1999) .
We identified 39 protein spots on two-dimensional gels (2-D) that changed obviously in response to treatment with UP inhibitors. In all, 11 of them were new apoptosis-associated proteins. We chose one of the novel findings, UP inhibitor-induced accumulation of eukaryotic initiation factor 5A (eIF-5A), for a further analysis, and found that the hypusine formation in eIF-5A was suppressed during MG-132-induced apoptosis, and the eIF-5A accumulation was regulated in a UPdependent manner. The roles of eIF-5A modification and accumulation in UP inhibitor-induced apoptosis were investigated, and the function of hypusine formation in apoptosis was further revealed to be associated with the subcellular localization of eIF-5A.
Results

Two-dimensional proteome maps to identify changes in protein expression stimulated by proteasome inhibitors
Treatment of Mo7e cells with MG-132 induced apoptosis in a dose-dependent manner (Figure 1a, b) . At the highest dose used in this study, MG-132 caused about 100% cell death in Mo7e cell cultures within 24 h. That MG-132 induced apoptosis in Mo7e cells was demonstrated by the appearance of marked nuclear fragmentation and chromatin condensation in cells after staining with Acridine Orange. To identify changes in protein expression in response to treatment with the proteasome inhibitors, we compared the proteome of Mo7e leukemic cells with that of the same cells stimulated with UP inhibitors (MG-132 or lactacystin). To detect rapid and prolonged changes in protein expression, cells were treated with MG-132 or lactacystin for 2, 6, 12 and 24 h, respectively. Cell lysates were resolved by 2-D. We reproducibly detected more than 1000 protein spots on 2-D gels after silver staining (Figure 1c, d ). Landmark protein spots (such as actin and others) did not change upon inhibitor treatment and were chosen to use for standardization. We ran and analysed at least five gels for each experimental time point.
From the gels, we noticed 39 protein spots, which were obviously changed in their expression in response . At the end of the treatment, total cell lysates (125 mg) were subjected to 2-D analysis, and detected by silver staining. The pH gradient of the first-dimension electrophoresis is shown on top of the gel, and migration of molecular mass markers for SDS-PAGE in the second dimension is shown on the left side. The original gel size was 20 Â 20 Â 0.1 cm 3 to the treatment with both MG-132 and lactacystin. All of the spots marked in Figure 1 (c and d) were distributed in pI 3-10 and their molecular masses ranged 14-40 kD. The 39 spots selected were subjected to in-gel trypsin digestion and analysis with matrixassisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) and nanoelectrospray tandem mass spectrometry (ESI-MS/MS) ( Table 1 ). The reliability of those results identified by peptide massfingerprinting (PMF) was evaluated by MOSCOW values and sequence coverage. For those identifications that can not be concluded by PMF results, ESI-MS/MS were used to sequence at least two peptides chosen from the corresponding PMF, and the identification was made in case the sequence-based search result was the same as that by PMF. The technical details for ESI-MS/ MS identification have been described in our previous technical report . The results showed that one protein among them was a structural component, while others were proteins with functions primarily in regulatory pathways or processes (Table 1) . To investigate the universal significance of the effects of UP inhibitors, the effects of another UP inhibitor lactacystin on TF-1 and THP-1 leukemic cells, COS-7 cell and HEK293 cells have also been observed with the similar results (data not shown).
Clustering of identified proteins
We found that the expression of 77% of the proteins identified (30 of 39) was increased 24 h after MG-132 treatment (Table 1) , possibly due to the inhibition of the UP-mediated degradations. Eight proteins showed biphasic expression, with an increase within 6 or 12 h of MG-132 treatment, followed by a return to the level in untreated cells or to varied lower level. Only nine proteins were downregulated 24 h after incubation with MG-132 (Table 1) . The MG-132-dependent accumulation of some proteins and decrease of other proteins indicate that changes described here are specific and not due to a nonselective effect of MG-132.
The identified proteins, affected by UP inhibitors, are involved in different cellular functions (Table 1) , including signal transduction, transcription, intracellular transport, ionic homeostasis, stress and defense, cellular organization, protein synthesis, protein degradation and metabolism. A total of 28 proteins identified have been known before to be associated with apoptosis. For example, we found enhanced expression of HSP27 only after 2 h of incubation with MG-132, and this was in agreement with the previous report on MG-132-induced apoptosis (Ito et al., 2002) . In all, 11 of the 39 proteins identified have not been described before to be involved in apoptosis. Identification of these targets suggested novel ways of MG-132 effects in the intracellular regulatory network, and remain to be further investigated.
Since UP inhibitors activated caspase-3, which leads to some cleavage of proteins (Zhang et al., 1999) , we tried to find out if some protein changes in 2-D resulted from caspase-3 activation. As indicated in Figure 2a , an accumulation of 22 kDa Rho-GDI2 (G, H, F spots) was accompanied by a decrease of 26 kDa Rho-GDI2 (h spot), identified by PMF and peptide sequence tag (PST) . By matching the PMF between them, we found the absence of the N-terminal sequence (1-20) in H spot, but not in h spot. The MW and pI of Rho-GDI2 in H spot matched the theoretical values of caspase-3-cleaved Rho-GDI2 fragment at Asp
19
. Treatment with DEVD-CHO, a caspase-3 inhibitor, effectively inhibited the MG-132-induced alterations in the spots. Taken together, the MG132-induced change of Rho-GDI2 protein was associated with caspase-3 activation (Essmann et al., 2000) . YVAD-CHO, a caspase-1-specific inhibitor, had no similar effect (Figure 2b ). Interestingly, G and F spots, also identified as Rho-GDI2, had minor differences from H spot in MW and pI, which were possible results of unknown modifications. The similar inhibition by DEVD-CHO was also observed in W spot identified as profilin 1. The effect of caspase-3 activation on profilin1 required to be further explored.
Ms identification of eIF-5a and its modification
We selected one of the novel findings that UP inhibitors accumulated eIF-5A for a further analysis. Since eIF-5A is essential for cell survival and proliferation, it is possible that regulation of UP inhibitors on eIF-5A expression can provide insight into the mechanisms of UP inhibitor-induced apoptosis. The treatment of Mo7e leukemic cells with MG-132 downregulated eIF-5A in m spot, while induced an accumulation of it in T spot, both of which altered in a time-dependent manner ( Figure 3a) . The two protein spots below T spot can be viewed as control as they did not change upon MG-132 treatment, proving the reliability of the alterations.
The eIF-5A identification for T spot was first made by the approach of PMF using MALDI-TOF-MS (Figure 3b ). After database searching with PMF, protein score is significant (Po0.05) and the sequence coverage (matched peptides) reached 86%, with a difference between measured and calculated masses below 0.3 D. The analysis of PMF has been made for at least five samples from five independent experiments, and the combining coverage exceeded 95%. Furthermore, three peptides chosen from the PMF were subjected to a sequence analysis by nano-ESI-MS/MS, and one representative data is shown in Figure 3c , which was consistent with the analysis by PMF.
The eIF-5A identification for m spot has also been made according to the same methods (Figure 3d, e) . However, in the PMF for m spot, we found a peak of MW 922.58 peptide ( Figure 3D ), whose deduced sequence after database searching included hypusine 50 (48-55: TG-hypusine-HGHAK), which did not exist in the PMF for T spot. The equivalent peptide (including lysine 50 , rather than hypusine 50 ) in the PMF was also not detected in T spot (Figure 3b) , which implied a possible special physical nature with it. To explore it, the Glu-Cdigested T spot instead of the trypsin-digested one was The calculation of experimental pI and M r was based on migration of the protein spot on 2-D gels. m means the protein increased in response to MG-132 treatment; k means the protein decreased in response to MG-132 treatment and mk indicates biphasic protein expression pattern. '+' shows PST identification has been done, 'À' shows no PST identification. 'Y' shows the protein has been known to relate to apoptosis, 'N' shows no report of its involvement in apoptosis subjected to the PMF analysis by MALDI-TOF-MS. In the PMF of the Glu-C-digested T spot (Table 2) , a fragment of MW 3069.68 peptide was found and its deduced sequence after database searching was: (43-70) MSTSKTG-lysine 50 -HGHAKVHLVGIDIFTGKKYE. This showed that the lysine 50 was not processed through the post-translational modification into hypusine in eIF-5A for T spot, suggesting that MG-132 induced the accumulation of hypusine-absent eIF-5A. We tried to use an alternative approach of Western blot to demonstrate the results above. Using polyclonal antibodies against eIF-5A, we observed only one band of eIF-5A expression (Figure 3f ), which decreased gradually with the treatment by MG-132 and was possibly equivalent to m spot in 2-D gel. The exact reason remains to be further investigated. It is very possible that the UP inhibitor affects synthesis of eIF-5A/ stability of the unmodified protein in addition to affecting the modification. Another plausible explanation might be due to the results of its dramatic changes in spatial structure.
Effect of the accumulated eIF-5a in apoptosis
To further explore the role of the accumulated unmodified eIF-5A in UP inhibitor-induced apoptosis, we analysed the effect of eIF-5A modification or expression in the apoptosis. Post-translational modification of eIF-5A by spermidine could be inhibited by diaminoheptane (DAH), a competitive inhibitor of the addition of the butylamine moiety of spermidine to lysine 50 in the modification reaction for hypusine formation (Jakus et al., 1993 , Tome et al., 1997 . As indicated in Figure 4 (a, b), the addition of exogenous DAH induced apoptosis in Mo7e cells, suggesting that hypusine formation was essential for cell survival (Jakus et al., 1993 , Tome et al., 1997 . The apoptosis was confirmed by the appearance of a typical apoptotic body observed under electron microscopy ( Figure 4c ), and inhibition of hypusine formation with DAH triggered the activation of caspase-3 (Figure 4d ). Increased apoptosis is seen in cultures approximately 4 days after the addition of exogenous DAH, and the induction of apoptosis by inhibition of hypusine formation was obviously weaker compared to that caused by MG-132. A weak accumulation of unmodified eIF-5A on 2-D gels was observed after the treatment with DAH at its highest dose in this experiment (Figure 4e ), a similar result to previous biochemical analysis (Tome et al., 1997) . The survival of Mo7e cells in vitro is strictly dependent on exogenous GM-CSF (Zhang et al., 1999) , and the treatment of Mo7e cells with MG-132 markedly induced apoptosis in a dose-dependent manner. So we believe that inhibition of hypusine formation gave only partial explanation to the strong induction of apoptosis by UP inhibitors. To further investigate the effect of eIF-5A expression on cell proliferation, antisense oligodeoxynucleotides (ODNs) were used. No obvious effects of antisense eIF-5A ODN on Mo7e cell growth in the absence of rhGM-CSF were observed; however, we found that the treatment with antisense eIF-5A ODN significantly enhanced the stimulating effect of GM-CSF on cell growth (Figure 4f ). Western blot analysis confirmed that reduction of eIF-5A protein levels occurred following ODN treatment (Figure 4g ).
Proteasome-dependent regulation of unmodified eIF-5A
Hypusine modification ensues immediately following the translation of the eIF-5A precursor, so the unmodified eIF-5A was very difficult to be detected. Even when Mo7e cells are treated with the modification inhibitors DAH at 400 mm, only a weak spot of unmodified eIF-5A protein was observed on 2-D gels, similar to previous The Glu-C-digestic fragment masses (obtained and indicated in daltons) and their corresponding matches to theoretical masses are listed. The amino-acid sequences were deduced after database searching, and miss means incomplete cleavage biochemical analysis (Tome et al., 1997) . However, the MG-132-induced accumulation of unmodified eIF-5A was much stronger than the effect of DAH (Figure 4e ), and this has not been reported before. To further confirm it, we performed additional experiments using TF-1 leukemic cells. As shown in Figure 5 , the accumulation of hypusine-absent eIF-5A was verified with lactacystin, another highly specific and irreversible proteasome inhibitor. However, similar accumulation was not detected in the same cells induced to apoptosis by non-UP apoptotic stimuli or inhibitors ( Figure 5 ). This implied the accumulation of hypusine-absent eIF-5A was possibly regulated in a UP-dependent manner.
Effect of hypusine formation in eIF-5A subcellular localization
To further investigate the mechanisms by which hypusine formation affects the function of eIF-5A in the apoptosis, we took advantage of the approach of GFP-tagging, which allows direct visualization of tagged eIF-5A protein (about 43 kDa) in vivo, since the information of protein localization can provide important clues on its function. GFP is an autofluorescent protein derived from the jellyfish Aequorea victoria and GFP tagging has been widely used as a marker for protein targeting and localization in living cells (Tsien and Miyawaki, 1998). Moreover, Chatterji has shown that GFP-eIF-5A fusion protein is fully functional (Jao and Chen, 2002). We found eIF-5A localized in both nucleus and cytoplasm just for a short time after its transient expression, then distributed steadily in only cytoplasm ( Figure 6 ). We found that hypusine formation was associated with eIF-5A localization. As revealed in Figure 6a , GFP-eIF-5A steadily localized in cytoplasm 48 h after transfection, but the localization was significantly changed in response to MG-132 stimulation, and the MG-132-altered eIF-5A finally localized with the pattern of the whole-cell distribution (Figure 6b, C-V) . This finding was also supported by another approach of inhibiting eIF-5A postmodification using DAH (Figure 6b , C-V) (Tome et al., 1997) . Moreover, the replacement of lysine 50 by alanine through mutation, excluding the possibility of hypusine formation, also affected its subcellular localization in the same way. This result helps us to understand the mechanisms that the Lys 50 -Arg variant is unable to stimulate methionyl-puromycin synthesis and interact with the ribosome (Hershey et al., 1990 , Park et al., 1991 . About the role of hypusine in the subcellular localization of eIF-5A, there had been a different report by Jao and Chen (2002), which was possibly due to the unknown of the dynamic change of hypusine-contained eIF-5A. We could conclude from our experiments that the localization alteration was one of the mechanisms by which UP inhibitors affected the functions of eIF-5A. We observed that UP inhibitors effect on unmodified eIF-5A accumulation are much stronger than those induced by DAH, while effects on subcellular localization of eIF-5A are smaller for the UP inhibitors compared to DAH. The plausible explanation is that unmodified eIF-5A induced by DAH is unstable, and its obvious accumulation occurred only in the condition where the UP pathway was inhibited. Actually, DAH at 400 mm almost completely inhibited cellular hypusine synthesis (Tome et al., 1997) . In another aspect, UP inhibitor effect on subcellular localization of eIF-5A actually was also very strong. In this experiment, we used UP inhibitor in a very low concentration (1 m) in order to observe the dynamic change of eIF-5A localization.
Discussion
Proteomic analysis of ubiquitin-proteasome effects
The UP system plays important roles in several biological processes, and represents one of the most important degradation systems for short-life regulatory proteins in cells (Hershko and Ciechanover, 1998; Lee and Goldberg, 1998; Pickart, 2001; Lin and Lechleiter, 2002) . In order to unravel the mechanisms by which UP inhibitors induced apoptosis in leukemic cells (Figure 1a and b), we completed an analysis of the global effect of UP inhibitors on leukemic cell proteome. The proteomic approach possibly provides us the changes of protein expressions and modifications in a panoramic view of and paves the way for a more detailed characterization of protein function. In our experiment, 39 protein spots changed in response to UP inhibitor stimulation were identified. Some of the identified targets suggested interesting possibilities of UP inhibitors interfering with cellular regulation, including molecular transport, protein synthesis, transcription, signal transduction, chloride homeostasis, cellular organization, cell rescue and defense, metabolism and structural proteins (Table 1) .
Many of the identified targets suggest some interesting effects of UP inhibitors in apoptosis. Among them, PPIase 1 showed biphasic expression, with an increase within 6 h of MG-132 treatment, followed by a return to the level in untreated cells (Table 1) . No effect of UP inhibitors on PPIase 1 was described before, but PPIase 1 activity was required for the function of cyclophilin D in protecting cells against apoptosis (Lin and Lechleiter, 2002) , supporting the possible effects of PPIase 1 in UP inhibitor-induced apoptosis. The accumulated stathmin, regulated by MG-132, is a major cytosolic phosphoprotein constituent in leukemia cells and a main target of the Raf/MEK/ERK kinase cascade (Melhem et al., 1997; Lovric et al., 1998) , playing important roles in cell growth (Melhem et al., 1997) . We observed the upregulations of profilin1 and high mobility group protein 1, which were both mentioned in preleukemic thymuses and related to alterations of cell cycle and apoptosis (Verlaet et al., 2001; Witke et al., 2001) . Heatshock protein 27, upregulated by MG-132 (Table 1) (Ito et al., 2002) , was found to correlate with the susceptibility to carcinoma development (Soldes et al., 1999) . Our proteomic results required more detailed characterization of their functions by other approaches.
eIF-5A modification, expression and apoptosis.
eIF-5A precursor is the only cellular protein known to contain a specific lysine residue that is transformed into the unique amino acid hypusine following post-translational modification (Chen and Park et al., 1997; Chen and Jeo, 1999) . Hypusine plays a key role in the regulation of eIF-5A function, which is believed to promote the formation of the first peptide bond during the initial stage of protein synthesis (Park et al., 1997) . Actually, the in vivo function of eIF-5A is still only partially known. Hypusine-containing eIF-5A is not required for global protein synthesis, appearing to facilitate the translation of specific subsets of mRNA required for cell division (Kang and Hershey, 1994) . Moreover, agents that block the lys/hyp transformation inhibit the growth of mammalian cells, inducing reversible arrest at the G1/S boundary of the cell cycle (Park et al., 1997) . More recently, a correlation has been found between the modification of eIF-5A and the triggering of apoptosis in tumour cells (Caraglia et al., 2001) .
Similarly, upon treatment of Mo7e cells with DAH in our experiments, dose-dependent apoptosis and inhibition of cellular proliferation were observed. However, of particular interest is the finding that eIF-5A expression inhibition by antisense ODNs significantly enhanced the stimulating effect of GM-CSF on cell growth, although there was no effect on cell growth without GM-CSF stimulation. The result implied a challenge to the currently known eIF-5A function to be essential to cell viability. The function of eIF-5A was almost established on the evidence that hypusine formation in eIF-5A is absolutely necessary to cell proliferation. Thus, we want to further know whether it is the decrease of modified eIF-5A, or the accumulation of unmodified eIF-5A, that leads to the inhibition of cell growth when hypusine formation is suppressed. Our results showed the promoting effects of eIF-5A decrease on GM-CSFstimulating cell growth, ruling out the possibility that the decrease of modified eIF-5A led to apoptosis. Therefore, we could conclude from it that the accumulation of hypusine-absent eIF-5A, identified through proteomics, played an important role in the strong induction of apoptosis by UP inhibitors.
Proteasome-dependent regulation of hypusine-absent eIF-5A
Hypusine formation apparently ensues immediately following translation of eIF-5A precursor (lysine form) or eIF-5A intermediate (deoxyhypusine form) unless cells are treated with inhibitors of either deoxyhypusine synthase or deoxyhypusine hydroxylase. Our experiments showed,even in the presence of DAH at 400 mm, almost complete inhibition of cellular hypusine synthesis; only a slight spot of unmodified eIF-5A was observed in 2-D (Figure 4e ), similar to previous biochemical analysis (Tome et al., 1997) . However, UP inhibitors induced a much stronger accumulation of unmodified eIF-5A compared to the effect of DAH (Figure 4d ), which has not been described before. Moreover, the accumulation of hypusine-absent eIF-5A was further verified with another UP inhibitor lactacystin, but not with nonproteasome inhibitors or apoptotic stimuli ( Figure 5 ). These data implied that the accumulated eIF-5A was regulated in a UP inhibitordependent manner. In light of the fact that DAH induced about 40% apoptosis, which required 5-6 days, with trace amount of unmodified eIF-5A, we strongly suggested the important roles of the accumulation of the unmodified eIF-5A in the strong induction of apoptosis by UP inhibitors, reaching 100% cell death within 24 h.
Hypusine formation and eIF-5A subcellular localization
The intracellular localization of eIF-5A has been previously studied, but with conflicting results (Ruhl et al., 1993; Shi et al., 1996; Jao and Chen, 2002) . eIF-5A was found in the cytoplasm: free or bound to the endoplasmic reticulum. Recently, eIF-5A was found to accumulate at nuclear pore-associated intranuclear filaments and interact with the general nuclear export receptor CRM1 and transport to cytoplasm (Rosorius et al., 1999) . More recently, Jao and Chen (2002) reported that eIF-5A is in whole-cell distribution in living cells. In this study, we found that eIF-5A localized in the nucleus as well as in the cytoplasm just for a short time after its transient expression, then distributed only in the cytoplasm (Figure 6b ,C-F), implied nuclear export of it. The movement of eIF-5A could only be observed in a living cell, rather than the cells processed through chemical fixation. The results have not been described before and provided evidence to the additional function of eIF-5A as a nucleocytoplasmic shuttle protein of mRNA.
An appreciable nucleocytoplasmic shuttling of eIF-5A has not been detected by the heterokaryon assay, but more evidence inclined to indicate this function of eIF-5A. Motif analysis revealed that eIF-5A has a bimodular structure, similar to RNA-binding proteins Shen et al., 2000) . X-ray diffraction studies showed that eIF-5A is composed of two domains and both have the potential to interact with nucleic acids (Xu and Chen, 2001 ). Moreover, eIF-5A could interact with general nuclear export receptor and transport to the cytoplasm, consistent with the theoretical analysis that eIF-5A does not contain a functional nuclear localization signal, but contains a sequence of the nuclear export signal . The nuclear export of eIF-5A was demonstrated in vitro by either microinjection or cell permeabilization using exogenously added eIF-5A (Rosorius et al., 1999; Lipowsky et al., 2000) , which gave rise to doubts on their reliability since they both resulted in very high concentration of eIF-5A in the nucleus. Our results observed the dynamic changes of eIF-5A localization and provided the in vivo data to the function of eIF-5A.
The present study is the first to show the role of hypusine formation in eIF-5A localization. Inhibition of hypusine formation resulted in the alteration of eIF-5A subcellular localization. Further, the MG-132-induced change of eIF-5A localization was demonstrated by an alternative method of inhibiting hypusine formation using DAH, and another study using the Lys 50 -Ala variant, which is unable to form hypusine. The role of hypusine in eIF-5A biological activity and its interaction with the ribosome was once reported by previous studies that the hypusine-absent variant is unable to stimulate methionyl-puromycin synthesis in vitro (Hershey et al., 1990; Park et al., 1991) . Another similar report also showed that hypusine formation is apparently part of the signal that allows eIF-5A to access the exportin-4 pathway (Caraglia et al., 2001) . The changes of eIF-5A subcellular localization caused by inhibition of hypusine formation make it unable to localize at its proper site of normal action. While it is currently unclear how the unmodified eIF-5A activates caspase-3 ( Figure 5d ) and induces apoptosis, it is very likely that eIF-5A localization is very important for cell proliferation.
Conclusion/perspectives
We have completed an analysis of the effect of UP inhibitors on leukemic cell proteome. A total of 39 protein spots changed in response to UP inhibitor stimulation were identified. We found that hypusine formation in eIF-5A was suppressed and the unmodified eIF-5A was accumulated, which had important roles in UP inhibitor-induced apoptosis. Hypusine inhibition resulted in unmodified eIF-5A accumulation, which was regulated in a UP-dependent manner. Moreover, change of eIF-5A localization occurred upon hypusine inhibition, and was one of the mechanisms that mediated the apoptosis. A more detailed knowledge of the effect of UP inhibitor on cell proteome paves the way to a better understanding of the mechanisms by which components of the UP system have been linked to apoptosis.
Materials and methods
Cells and reagents
The Mo7e megakaryoblastic leukemia cell line was a gift from Dr S Clark of Genetic Institute (Boston, MA, USA). This cell line was maintained in Dulbecco's modified Eagle's medium (DMEM, Life Technologies) supplemented with 10% FCS and 1-10 ng/ml rhGM-CSF unless otherwise noted. HEK293, COS-7 cells were obtained from ATCC (Manassas, VA, USA), cultured in DMEM with 10% FCS. The polyclonal anti-eIF5A antibody was kindly provided by Dr MH Park in National Institutes of Health (NIH). Polyclonal rabbit anti-(caspase 3) antibodies were purchased from PharMingen (San Diego, CA, USA). Proteasome inhibitors MG-132 and lactacystin were from Calbiochem (USA). DAH and trypan blue were obtained from Sigma Chemical Co. (St Louis, MO, USA).
Sample preparation
Cells were washed with chilled phosphate-buffered saline, and cell lysates were then prepared on ice using cool lysis buffer (8 m urea, 4% CHAPS, 40 mm Tris) containing a protease inhibitor cocktail (Roche Diagnostic). After 30 min of gentle stirring at 41C, the sample was centrifuged at 12 000 g (Eppendorf, Hamburg, Germany) for 30 min. Collecting the supernatant and protein concentration was determined using the Bradford method. Then, the lysates were aliquoted and stored at -701C until use.
Two-dimensional electrophoresis
2-D was performed as described by Go¨rg et al. (1988) . Briefly, isoelectric focusing was performed with the IPGphor system (Amersham Pharmacia Biotech, Uppsala, Sweden). Immobiline 3-10 linear DryStrips (Pharmacia Biotech) were rehydrated for 10 h using reswelling buffer (8 m urea, 2% CHAPS, 20 mm dithiothreitol) and IPG Buffer (0.5%). SDS-PAGE was performed using 13% polyacrylamide gels without a stacking gel in the PROTEAN II cell (Bio-Rad company). Following SDS-PAGE, gels were stained with 0.1% (w/v) Coomassie Blue G-250 in 50% methanol and 10% acetic acid, or silver staining according to the protocol of Shevchenko et al. (1996) , and gel image analysis was processed using Adobe Photoshop software and the Diversity One program (Pharmacia).
In-gel digestion
In-gel digestion was performed using a modified version of previously published protocol (Gamble et al., 2000) . Briefly, protein spots were excised from 2-D gels stained with Coomassie Blue G-250 and were destained by washing in 200 ml aliquots of 50 mm ammonium bicarbonate in 50% v/v acetonitrile for 30 min. The gel pieces were then dried in a SpeedVac Vacuum (Savant Instruments, Holbrook, NY, USA) and rehydrated at 41C for 30 min in 10 ml digestion solution (25 mm ammonium bicarbonate and 0.01 mg/ml modified sequence-grade trypsin), 4-10 ml of digestion solution without trypsin was then added to keep the gel pieces wet during the digestion. After overnight incubation at 371C, the digestion was stopped with 5% trifluoroacetic acid (TFA) for 20 min. Peptides were extracted by 20 ml 5% TFA for 1 h at 371C and then by 20 ml 2.5% TFA/50% acetonitrile for 1 h at 371C. The combined supernatants were evaporated in the SpeedVac Vacuum and dissolved in 4 ml 0.5% aqueous TFA for mass spectrometric analysis.
Peptide mass fingerprinting by MALDI-TOF-MS
All mass spectra of MALDI-TOF-MS were obtained on a Bruker REFLEX III MALDI-TOF-MS (Bruker-Franzen, Bremen, Germany) in positive ion mode at an accelerating voltage of 20 kV with the matrix of a-cyano-4-hydroxy cinnamic acid. The spectra were internally calibrated using trypsin autolysis products. PMF obtained was used to search through the SWISS-PROT and NCBInr database by the Mascot search engine (http://www.matrixscience.co.uk) with a tolerance of 7B0.1 D and one missed cleavage site.
Peptide sequencing by ESI-MS/MS
ESI-MS/MS experiments were performed on a Q-TOF2 hybrid quadrupole/TOF mass spectrometer (Micromass, UK) with a nanoflow Z-spray source. Peptide sequencing was performed using palladium-coated borosilicate electrospray needle (Protana, Denmark) according to the method of Yan et al. (2000) . The mass spectrometer was operated in the positive ion mode with a source temperature at 801C, and a potential 800-1000 V applied to the Nanospray probe. The amino-acid sequences of the peptides were deduced with the peptide sequencing program MasSeq. The database search was finished with the Mascot search engine (http://www.matrixscience.co.uk) using the data processed through MaxEnt3 and MasSeq.
Western blotting
Whole-cell lysate (20 mg) in 1 Â SDS loading buffer was subjected to electrophoresis in 12% SDS-PAGE at 100 V. The gel was transferred onto 0.2 mm pore NC membrane at 40 V for 1 h. The membrane was then blocked with 3% nonfat milk and probed with anti-eIF5A polyclonal antibody at a 1 : 500 dilution. After being washed, the membranes were incubated with a 1 : 2000-diluted horseradish peroxidase-conjugated antirabbit immunoglobulin. Antibody-antigen complexes were detected using an ECL chemiluminescence kit according to the manufacturer's instructions (Amersham Life Science).
Antisense ODN synthesis and treatment of cells
ODNs used in this study were synthesized by Sangon Inc. (China). The sequence of antisense ODN corresponds to the translation initiation site of the eIF-5A. Mismatch sequence was used as control and had no similarity in sequence to other mammalian genes and also exhibited minimal self-complementarity. Lipofectamine, a cationic lipid (Life Technologies, Inc.), was used to increase the ODNs uptake by the cells. Mo7e cells were treated with various concentrations of ODNs in the presence of GM-CSF in 96-well plates after a starvation in the cytokine-free medium for 24 h. At 5 h after the beginning of transfection, the standard culture medium (DMEM, 10% FCS) were added. The 3 H-TdR (0.5 mCi per well, Amersham) incorporation was performed during the last 4 h at 371C. After incubation, cells were harvested on filter paper and the degree of radioactivity was determined using a scintillation counter. For Western blot analysis, various concentrations of ODN in the presence of lipofectamine were added to cell suspensions in six-well (35 mm) tissue culture plates.
Constructs, transient transfection and confocal imaging acquisition
A 462-bp fragment of eIF-5A was first obtained by RT-PCR from Mo7e cells. Mutation of lysine 50 residues by alanine was performed through the PCR method. The open reading frame of eIF-5A was then subcloned into pEGFP-N1 vector (Clontech). The construct was sequenced to ensure that no PCR error was introduced. HEK293 or COS-7 cells were transiently transfected by LipofectAMINE (Life Technologies, Inc.). Confocal microscope images were obtained with a Radiance 2100 hardware and Lasersharp 2000 Software (BioRad).
